设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
CNKI学位论文(21)
知网期刊论文(16)
在“
Elsevier电子期刊
”中,
命中:
35
条,耗时:小于0.01 秒
在所有数据库中总计命中:
37
条
1.
Considerations for the Design of Future Clinical Trials in Metastatic Renal Cell Carcinoma
作者:
Bernard Escudier
;
Daniel Y.C. Heng
;
Arthur Smyth-Medina
;
Camillo
Porta
关键词:
Kidney cancer
;
Outcomes
;
Studies
;
Targeted therapy
刊名:Clinical Genitourinary Cancer
出版年:February, 2014
2.
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial
作者:
Dr Prof Robert J Motzer
;
MD
a
;
motzerr@mskcc.org" class="auth_mail
;
Camillo
Porta
;
MD
b
;
Prof Nicholas J Vogelzang
;
MD
c
;
Cora N Sternberg
;
MD
d
;
Prof Cezary Szczylik
;
MD
e
;
Jakub Zolnierek
;
MD
f
;
Christian Kollmannsberger
;
MD
g
;
Sun Young Rha
;
MD
h
;
Georg A Bjarnason
;
MD
i
;
Prof Bohuslav Melichar
;
MD
j
;
Ugo De Giorgi
;
MD
k
;
Prof Viktor Grü
;
nwald
;
MD
l
;
Ian D Davis
;
MBBS
m
;
Prof Jae-Lyun Lee
;
MD
n
;
Prof Emilio Esteban
;
MD
o
;
Gladys Urbanowitz
;
MBA
p
;
Can Cai
;
PhD
p
;
Matthew Squires
;
PhD
q
;
Mahtab Marker
;
PhD
p
;
Michael M Shi
;
MD
p
;
Prof Bernard Escudier
;
MD
r
刊名:Lancet Oncology
出版年:March, 2014
3.
Reply from Authors re:
Camillo
Porta
, Chiara Paglino. Experience Gathered from Retrospective Series on Renal Cell Carcinoma Is Useful, But Now It Is Time for a Global Claim for Academically Driven Prospective Studies. Eur Urol 2013;64:71-2: Are Retrospect
作者:
Steffen Weikert
a
;
steffen.weikert@charite.de
;
Viktor Grü
;
nwald
b
刊名:European Urology
出版年:2013
4.
Adjuvant Treatment for Resected Renal Cell Carcinoma: Are All Strategies Equally Negative? Potential Implications for Trial Design With Targeted Agents
作者:
Francesco Massari
;
Emilio Bria
;
Francesca Maines
;
Michele Milella
;
Diana Giannarelli
;
Francesco Cognetti
;
Giovanni Pappagallo
;
Giampaolo Tortora
;
Camillo
Porta
关键词:
Adjuvant
;
Interaction
;
Meta-analysis
;
Renal cell carcinoma
刊名:Clinical Genitourinary Cancer
出版年:December, 2013
5.
Evidence and experience for the management of metastatic renal cell carcinoma
作者:
Manuela Schmidinger
;
James Larkin
;
Camillo
Porta
关键词:
Metastatic renal cell carcinoma
;
mRCC
;
Sunitinib
;
Axitinib
;
Temsirolimus
;
Guidelines
;
Sequencing
刊名:European Journal of Cancer Supplements
出版年:2013
6.
Reply to Giuseppe Procopio, Elena Verzoni and Filippo De Braud's Letter to the Editor re:
Camillo
Porta
, Emiliano Calvo, Miguel A. Climent, et al. Efficacy and Safety of Everolimus in Elderly Patients with Metastatic Renal Cell Carcinoma: An Exploratory A
作者:
Camillo
Porta
a
;
c.
porta
@smatteo.pv.it
;
Robert J. Motzer
b
刊名:European Urology
出版年:2012
7.
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
作者:
Armando Santoro
;
MD
a
;
&dagger
;
;
Dr Lorenza Rimassa
;
MD
a
;
&dagger
;
;
lorenza.rimassa@cancercenter.humanitas.it
;
Ivan Borbath
;
MD
b
;
Bruno Daniele
;
MD
c
;
Stefania Salvagni
;
MD
d
;
Prof Jean Luc Van Laethem
;
MD
e
;
Hans Van Vlierberghe
;
MD
f
;
Prof Jö
;
rg Trojan
;
MD
g
;
Prof Frank T Kolligs
;
MD
h
;
Prof Alan Weiss
;
MD
i
;
Steven Miles
;
MD
j
;
Prof Antonio Gasbarrini
;
MD
k
;
Monica Lencioni
;
MD
l
;
Luca Cicalese
;
MD
m
;
Morris Sherman
;
MD
n
;
Cesare Gridelli
;
MD
o
;
Peter Buggisch
;
MD
p
;
Prof Guido Gerken
;
MD
q
;
Prof Roland M Schmid
;
MD
r
;
Corrado Boni
;
MD
s
;
Nicola Personeni
;
MD
a
;
Ziad Hassoun
;
MD
b
;
Giovanni Abbadessa
;
MD
t
;
Brian Schwartz
;
MD
t
;
Reinhard Von Roemeling
;
MD
u
;
Maria E Lamar
;
BA
t
;
Yinpu Chen
;
PhD
t
;
Camillo
Porta
;
MD
v
刊名:Lancet Oncology
出版年:2013
8.
Experience Gathered from Retrospective Series on Renal Cell Carcinoma Is Useful, But Now It Is Time for a Global Claim for Academically Driven Prospective Studies
作者:
Camillo
Porta
;
c.
porta
@smatteo.pv.it
;
Chiara Paglino
刊名:European Urology
出版年:2013
9.
Axitinib dose titration: what's the limiting factor?
作者:
Sebastiano Buti
;
Camillo
Porta
刊名:Lancet Oncology
出版年:November, 2013
10.
Re:
Camillo
Porta
, Emiliano Calvo, Miguel A. Climent, et al. Efficacy and Safety of Everolimus in Elderly Patients With Metastatic Renal Cell Carcinoma: An Exploratory Analysis of the Outcomes of Elderly Patients in the RECORD-1 Trial. Eur Urol 2012;61:82
作者:
Giuseppe Procopio
;
Giuseppe.Procopio@istitutotumori.mi.it
;
Elena Verzoni
;
Filippo De Braud
刊名:European Urology
出版年:2012
1
2
3
4
按检索点细分(35)
题名(4)
作者(25)
按出版年细分(35)
2027年及以后(4)
2013年(4)
2012年(8)
2011年(3)
2010年(4)
2009年(3)
2008年(4)
2007年(1)
2006年(1)
2005年(1)
2002年(1)
2000年及以前(1)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.